Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study

• Michelangelo Vestita, MD,
• Angela Filoni, MD,
• Domenico Bonamonte, MD, PhD,
• Paolo Annoscia, MD,
• Giuseppe Giudice, MD

Affiliations

Michelangelo Vestita, MD

University of Bari, Bari

Angela Filoni, MD

University of Bari, Bari

Domenico Bonamonte, MD, PhD

University of Bari, Bari

Paolo Annoscia, MD

University of Bari, Bari

Giuseppe Giudice, MD

University of Bari, Bari